Letter To The Editor: “Is There Any Benefit from Oral A-Tocopherol Administration in Hemodialysis Patients?”

Georgia Antoniadi Renal Unit, General Hospital of Serres, Serres, GreeceCorrespondence[email protected]

Theodoros Eleftheriadis Renal Unit, General Hospital of Serres, Serres, Greece

Vassilis Liakopoulos Nephrology Department, University Hospital of Larissa, Larissa, Greece

Ioannis Stefanidis Nephrology Department, University Hospital of Larissa, Larissa, Greece

Vassilis Vargemezis Nephrology Department, University Hospital of Trace, Alexandroupolis, Greece

REFERENCES

Hodkova M, Dusilova-Sulkova S, Kalousova M, Soukupova J, Zima T, Mikova D, Matous Malbohan I, Bartunkova J. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients. Ren Fail. 2006; 28(5)395–399
PubMed Web of Science ®Google Scholar
Ohkawa S, Yoneyama T, Shimoi K, Takita T, Maruyama Y, Kumagai H. Pro-oxidative effect of alpha-tocopherol in the oxidation of LDL isolated from co-antioxidant-depleted non-diabetic hemodialysis patients. Atherosclerosis. 2004; 176(2)411–418
PubMedGoogle Scholar
Antoniadi G, Eleftheriadis T, Liakopoulos V, Stefanidis I, Kakasi E, Vayonas G, Kortsaris A, Vargemezis V (2004) Prolonged oral a-tocopherol administration increases oxidative stress markers and anticardiolipin antibodies levels in hemodialysis patients. Blood Purif. 22nd Annual Meeting of the International Society of Blood Purification (ISBP), London, September, 3–52004. 22: 398
Google Scholar
Antoniadi G, Eleftheriadis T, Liakopoulos V, Kakasi E, Vayonas G, Kortsaris A, Vargemezis V. Effect of one-year oral a-tocopherol administration on anticardiolipin antibodies in hemodialysis patients. Ren Fail. 2005; 27: 193–198
PubMed Web of Science ®Google Scholar
Jiang Q, Christen S, Shigenaga MK, Ames BN. γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr. 2001; 74: 714–722
PubMed Web of Science ®Google Scholar
Handelman GJ, Machlin LJ, Fitch K, Weiter JJ, Dratz EA. Oral a-tocopherol supplementation decreases plasma γ-tocopherol levels in humans. J. Nutr. 1985; 115: 807–813
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Letter To The Editor: “Is There Any Benefit from Oral A-Tocopherol Administration in Hemodialysis Patients?”

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Letter To The Editor: “Is There Any Benefit from Oral A-Tocopherol Administration in Hemodialysis Patients?”

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date